丰源药业最资金流向,丰源药业千股千评,最新消息股本结构公司高管等资讯!想了解更多关于丰源药业资讯的信息请重视咱们的站。

通达信怎么导入自选股?通达信怎么导入自选股

丰源药业财务指标剖析

213006?213006

丰源药业财务指标

报告期2021-03-31同比改变2020-12-312020-09-302020-06-302020-03-31每股收益1.3656.76%9.963.161.367.56每股净财物2.7696.36%8.567.741.948.14每股本钱公积金6.3455.75%4.952.159.357.55每股未分配赢利6.7595.15%4.352.559.757.95每股运营现金流5.1354.64%3.81.08.26.4净财物收益率4.68.0%2.29.47.65.8出售毛利率3.02.4%1.68.85.03.4净赢利率2.68.0%9.27.45.63.8财物负债率1.02.4%8.06.644.02.2活动比率1.43.6%1.82.03.21.6速动比率2.83.0%2.23.41.532.73

我国银河证券官网,我国银河证券官网

丰源药业运营成绩(万元)

报告期2021-03-31同比改变2020-12-312020-09-302020-06-302020-03-31主经营务收入175753.93%19247209182259024262主经营务赢利259341.13%27606292783095032622管理费用15262.33%3198487065428214财务费用99913.53%11976132301490216574经营赢利182461.73%19918215902326224934加:投资收益266062.93%282782995031622526经营外收入21983.13%3870554272148886减:经营外开销105581.31%12230139021557417246赢利总额189182.51%20590222622393425605减:所得税272773.71%2894930621322931197净赢利28691.91%4541621378859557

股东的权力和责任?股东的权力和责任

丰源药业财物负债(万元)

报告期2021-03-31同比改变2020-12-312020-09-302020-06-302020-03-31活动财物112292.12%12901145731624517917长期投资195893.32%21261229332460526375固定财物283411.72%2951630875321291033无形财物27052.92%4377604977219393财物总计110651.12%12737144091608117753活动负债194251.32%21097227692444126113长期负债277852.52%2945731129321704负债算计33761.72%50486720839210064股东权益117361.92%13408150801675218424负债及股东权益总计200961.12%21768234402521727202

丰源药业现金及现金等价物净添加状况(万元)

报告期2021-03-31同比改变2020-12-312020-09-302020-06-302020-03-31货币资金的期末余额284562.32%30128318007042376减:货币资金的期初余额40483.52%57207392906410736现金等价物的期末余额124081.72%14080157521742419096减:现金等价物的期初余额207682.92%22440241122578427456现金及现金等价物净添加额291283.11%308003247213763048

丰源药业主经营务收入(亿元)丰源药业主经营务收入(亿元)